Partnering Solutions
-
Intelligent Trials: Design and Execute Faster Trials with AI-Powered Insights
11/19/2024
Explore how Intelligent Trials leverages the industry’s largest clinical dataset to accelerate enrollment, improve diversity, and provide real-time insights, ensuring efficient, data-driven trial success.
-
Advancing Your Product From Development To Commercialization
2/22/2023
Harnessing decades of global drug product development and commercialization, you can rely on PCI's integrated speed solutions to simplify the supply chain.
-
Transforming Clinical Trial Site Forecasting
10/30/2024
In today’s ever-evolving clinical trial space, managing the expenses associated with conducting a study is more important – and fraught – than ever before.
-
Full Service CRO And Regulatory Partner For Biologics
1/25/2024
Advancing biologics from start to finish is highly complex and full of challenges, requiring scientific strategies and implementation.
-
Biometrics
4/28/2021
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
Your Global CRO Partner In Oncology And Hematology
1/14/2025
Learn about an organization dedicated to providing personalized and adaptive trial solutions and managing complex oncology and hematology clinical trials.
-
Reimagining How You Bring Life-Changing Therapies To Patients
6/16/2025
Accelerate your therapy's path to market and create better experiences with the right partner to provide end-to-end Clinical Development expertise.
-
ClinCard
4/10/2018
With more than 7 million payments, ClinCard is the industry-leading method for automated participant payments, delivering unmatched simplicity, security, and global reach.
-
Early Phase Trials In Australia
9/6/2024
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
-
From Innovation To Patient Impact
9/3/2025
Biotech innovation is redefining the future of healthcare — but translating breakthroughs into patient impact requires the right partner.